Cryosite Ltd (ASX: CTE) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Cryosite Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $58.82 million
P/E Ratio 29.10
Dividend Yield 0.00%
Shares Outstanding 48.81 million
Earnings per share 0.038
Dividend per share 0.09
Year To Date Return 10.00%
Earnings Yield 3.44%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Cryosite Ltd (ASX: CTE)
    Latest News

    a woman
    ⏸️ Investing

    5 AWESOME biotechs that pay healthy dividends

    Are these 5 biotechs entering the BUY ZONE?

    Read more »

    a woman
    ⏸️ Investing

    How to use stock turnover to improve your investing

    Paying too much for liquidity? Don't be a sucker for high-turnover stocks.

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    06 Sep 2024 $0.0200 0.00% Final 10 Oct 2024
    07 Sep 2023 $0.0150 0.00% Final 06 Oct 2023
    15 Sep 2022 $0.0100 0.00% Final 14 Oct 2022
    14 Mar 2017 $0.0050 0.00% Interim 31 Mar 2017
    07 Sep 2016 $0.0050 0.00% Final 04 Oct 2016
    11 Mar 2016 $0.0050 0.00% Interim 31 Mar 2016

    CTE ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Cryosite Ltd

    Cryosite Ltd provides an integrated clinical trial logistics service, biological storage and sample management service, including the storage of cord blood stem cells for private use. It supports a diverse portfolio of materials, includingGood Manufacturing Practice (GMP) clinical trial products, Australian Register of Therapeutic Goods (ARTG) approved medicines, biologics, Research and Development materials, and medical devices, among others. The group's operating segmentsare: Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord blood. The majority of its revenue is generated from the Ambient, cold, and frozen segment, which provides storage and distribution of small-molecule drugs and related products requiring ambient, refrigerated, or frozen conditions.

    CTE Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    09 Feb 2026 $1.21 $0.10 9.09% 15,088 $1.19 $1.21 $1.19
    04 Feb 2026 $1.10 $0.04 3.77% 10,000 $1.10 $1.10 $1.10
    23 Jan 2026 $1.06 $0.00 0.00% 1,933 $1.06 $1.06 $1.06
    22 Jan 2026 $1.06 $0.05 4.95% 1,225 $1.06 $1.06 $1.06
    13 Jan 2026 $1.01 $0.00 0.00% 6,281 $1.02 $1.02 $1.01

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    27 Jun 2025 Mark Kerr Buy 75,000 $55,873
    On-market trade.
    07 Apr 2025 Mark Kerr Buy 231,453 $185,131
    On and off market trades.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Mark Gregory Kerr Non-Executive ChairmanNon-Executive Director Dec 2023
    Mr Kerr has a long career with public companies. He was also the founding Chairman of Think Childcare Group.
    Mr Andrew Kerr Executive Director Aug 2024
    Mr Kerr is an experienced financial services professional in both the Australian and international markets. He has previously worked at Macquarie Bank, Bank of America Merrill Lynch, and Meridian Energy Australia. He is Chair of Risk Committee.
    Mr Scott Thomas Non-Executive Director May 2024
    Mr Thomas has strong experience in the financial services profession both in Australia and the United Kingdom having held senior roles at ANZ and Vanguard Investments. He is Member of the Risk Committee.
    .
    Mr Hamish George Company Secretary Sep 2024
    -
    Jane Hao Chief Financial Officer
    -
    Hamish George Company Secretary
    -
    Alicia Steel General Manager
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Daltonvale Proprietary Limited (Kroger Property Invest A/C) 9,731,663 19.94%
    Mr Mark Gregory Kerr & Mrs Linda Marie Kerr (Lindmark Inv Staff S/F A/C) 7,231,453 14.82%
    Mr Gary Griffith Robins & Mr Allan James Robins (Robins Sf A/C) 4,033,030 8.26%
    Laurie Thomas Family Nominees Pty Ltd (Thomas Family S/F A/C) 4,000,000 8.20%
    Mr Andrew Kroger 3,165,263 6.48%
    Mr Alistair David Strong 2,100,000 4.30%
    Paradyce Pty Ltd (The Paradyce A/C) 2,075,000 4.25%
    Marensa Pty Ltd (Stewart Super A/C) 2,000,000 4.10%
    Bnp Paribas Nominees Pty Ltd (Ib Au Noms Retailclient) 1,209,093 2.48%
    Mutual Trust Pty Ltd 762,808 1.56%
    Bfa Super Pty Ltd (Gdn Super Fund A/C) 700,000 1.43%
    Bell Potter Nominees Ltd (Bb Nominees A/C) 670,406 1.37%
    Ginga Pty Ltd (Thomas G Klinger Family A/C) 563,957 1.16%
    Ginga Pty Ltd 504,000 1.03%
    Alicia Steel 500,000 1.02%
    Thirty Sixth Vilmar Pty Ltd 500,000 1.02%
    H F A Administration Pty Limited (Super Fund A/C) 480,000 0.98%
    Thirty Sixth Vilmar Pty Ltd 1 403,000 0.83%
    Sunnyit Pty Ltd (Sunnyit Superannuation A/C) 375,000 0.77%
    Mrs Jane Susan Milliken 350,917 0.72%

    Profile

    since

    Note